SRPT

#1868
Sarepta Therapeutics,, Inc. Common Stock
22.16 USD
+1.70%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
22.09
22.21
Yıllık Aralık
10.41
64.80
Günlük Değişim
+1.70%
Aylık Değişim
+34.30%
6 aylık değişim
+1.84%
Yıllık Değişim
-59.08%
Önceki Kapanış
21.79
Open
22.09
Bid
Ask
Low
22.09
High
22.21
Hacim
355
Open full chart

Financials

Overview Rapor Statistics
Quarterly Annual
  • Market Capitalization 2.33 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.02
Price to sales ratio
0.98

Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

Haberler